4-Methylphenyl 2-O-benzoyl-4-O-benzyl-3-O-(9-fluorenylmethoxycarbonyl)-6-O-levulinoyl-1-thio-β-D-glucopyranoside
4-Methylphenyl 2-O-benzoyl-4-O-benzyl-3-O-(9-fluorenylmethoxycarbonyl)-6-O-levulinoyl-1-thio-β-D-glucopyranoside is a strategically protected thioglycoside designed for controlled glycosylation in complex carbohydrate synthesis. This compound combines orthogonal protecting groups to enable precise sequential deprotection during oligosaccharide assembly.
Structural Features
Core framework:
- β-D-glucopyranose ring with a 4-methylphenylthio group at the anomeric position (C1), forming a stable thioglycoside donor for glycosidic bond formation.
Protection pattern:
Position | Protecting Group | Stability & Deprotection Method |
C2 | Benzoyl ester | Acid-stable; removed via alkaline hydrolysis |
C3 | Fmoc (9-fluorenylmethoxycarbonyl) | Base-labile; cleaved with 20% piperidine/DMF |
C4 | Benzyl ether | Acid-stable; removed via hydrogenolysis |
C6 | Levulinoyl ester | Acid-labile; cleaved under mild acidic conditions (pH 4.5) |
Key Properties
- Molecular formula: C₄₈H₄₅NO₉S (estimated based on substituent masses)
- Molecular weight: ~836.0 g/mol
- Physical form: White crystalline solid (typical for protected carbohydrates)
- Reactivity:
- Activatable via thiophilic promoters (e.g., NIS/TfOH) for glycosylation
- Electron-withdrawing benzoyl group moderates donor reactivity
Synthetic Utility
- Orthogonal deprotection sequence:
- Step 1: Fmoc removal at C3 (base) without affecting other groups
- Step 2: Levulinoyl cleavage at C6 (mild acid)
- Step 3: Benzoyl removal at C2 (alkaline conditions)
- Step 4: Final benzyl deprotection at C4 (H₂/Pd-C)
- Solid-phase compatibility:
- Fmoc group enables use in automated synthesis platforms
- Levulinoyl permits temporary protection during chain elongation
- Branch-selective functionalization:
- Exposed C3/C6 hydroxyls after deprotection allow site-specific modifications
Applications
- Glycoconjugate vaccine development: Controlled exposure of hydroxyl groups for antigen coupling
- Glycosidase inhibitor synthesis: Serves as a protected glucose scaffold for analog design
- Dendrimer construction: Enables iterative branching through sequential deprotection
Stability Profile
Condition | Stability |
Acidic (pH > 3) | Stable (levulinoyl intact) |
Basic (pH < 9) | Stable except during Fmoc removal |
Hydrogenation | Stable until final deprotection step |
The compound exemplifies advanced carbohydrate engineering, merging traditional protecting groups (benzyl, benzoyl) with modern orthogonal motifs (Fmoc, levulinoyl) for precision in glycan assembly. Its design allows compatibility with both solution-phase and solid-phase synthesis methodologies.
Citations:
- https://synthose.com/products/ML822
- https://patents.google.com/patent/WO2019206853A1/en
- https://synthose.com/products/MG340
- https://patentimages.storage.googleapis.com/c4/a8/90/85cbb5f7ecd198/US7511022.pdf
- https://pubchem.ncbi.nlm.nih.gov/compound/1-Benzyl-4-_4-methylphenyl_-1h-1_2_3-triazole
- https://www.bocsci.com/product/4-methylphenyl-2-o-benzoyl-3-4-di-o-benzyl-6-o-9-fluorenylmethoxycarbonyl-339431.html
- https://patents.google.com/patent/WO2018053215A1/en
- https://www.chemicalbook.com/ProdSupplierGWCB29036383_EN.htm
Reviews
There are no reviews yet.